BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1022 related articles for article (PubMed ID: 16338281)

  • 21. Should intravenous tocolysis be considered beyond 34 weeks' gestation?
    Jones SC; Brost BC; Brehm WT
    Am J Obstet Gynecol; 2000 Aug; 183(2):356-60. PubMed ID: 10942469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive tocolysis does not prolong pregnancy or reduce neonatal morbidity after preterm premature rupture of the membranes.
    Combs CA; McCune M; Clark R; Fishman A
    Am J Obstet Gynecol; 2004 Jun; 190(6):1723-8; discussion 1728-31. PubMed ID: 15284781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
    Rozenberg P; Chauveaud A; Deruelle P; Capelle M; Winer N; Desbrière R; Perrotin F; Bohec C; Connan L; Vayssière C; Langer B; Mantel A; Azimi S; Porcher R; Azria E;
    Am J Obstet Gynecol; 2012 Mar; 206(3):206.e1-9. PubMed ID: 22381603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.
    Van De Water M; Kessel ET; De Kleine MJ; Oei SG
    Acta Obstet Gynecol Scand; 2008; 87(3):340-5. PubMed ID: 18307075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of aggressive tocolysis for preterm labor with advanced cervical dilatation.
    Psomiadis N; Goldkrand J
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):47-52. PubMed ID: 16105791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal morbidity between 34 and 37 weeks' gestation.
    Fox MD; Allbert JR; McCaul JF; Martin RW; McLaughlin BN; Morrison JC
    J Perinatol; 1993; 13(5):349-53. PubMed ID: 8263618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor.
    Sayin NC; Varol FG; Balkanli-Kaplan P; Sayin M
    J Perinat Med; 2004; 32(3):220-4. PubMed ID: 15188794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-Agonist tocolytic therapy.
    Lam F; Gill P
    Obstet Gynecol Clin North Am; 2005 Sep; 32(3):457-84. PubMed ID: 16125044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tocolysis does not improve neonatal outcome in patients with preterm rupture of membranes.
    Jazayeri A; Jazayeri MK; Sutkin G
    Am J Perinatol; 2003 May; 20(4):189-93. PubMed ID: 12874729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nifedipine first choice in management of threatening preterm labor].
    Papatsonis DN; Timmerman CC; Oei SG; van Geijn HP
    Ned Tijdschr Geneeskd; 2002 Oct; 146(42):1980-3. PubMed ID: 12420423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance tocolysis.
    Thornton JG
    BJOG; 2005 Mar; 112 Suppl 1():118-21. PubMed ID: 15715609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
    Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
    Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype related differences in beta2 adrenergic receptor density and cardiac function.
    Snyder EM; Hulsebus ML; Turner ST; Joyner MJ; Johnson BD
    Med Sci Sports Exerc; 2006 May; 38(5):882-6. PubMed ID: 16672841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tocolysis with the beta-adrenomimetic Partusisten in premature labor].
    Ivanov S
    Akush Ginekol (Sofiia); 1997; 36(2):9-10. PubMed ID: 9471910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gestagen treatment enhances the tocolytic effect of salmeterol in hormone-induced preterm labor in the rat in vivo.
    Gálik M; Gáspár R; Kolarovszki-Sipiczki Z; Falkay G
    Am J Obstet Gynecol; 2008 Mar; 198(3):319.e1-5. PubMed ID: 18313455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The case for tocolysis in threatened preterm labour.
    Fisk NM; Chan J
    BJOG; 2003 Apr; 110 Suppl 20():98-102. PubMed ID: 12763122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of tocolytic therapy with antenatal steroid administration and infant outcomes. Newborn Lung Project.
    Palta M; Sadek M; Lim TS; Evans M; McGuinness G
    Am J Perinatol; 1998 Feb; 15(2):87-92. PubMed ID: 9514131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy and economic outcomes in patients treated for recurrent preterm labor.
    Fleming A; Bonebrake R; Istwan N; Rhea D; Coleman S; Stanziano G
    J Perinatol; 2004 Apr; 24(4):223-7. PubMed ID: 14999214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nitroglycerin patch for tocolysis--a prospective randomized comparison with fenoterol by infusion].
    Schleussner E; Richter S; Gross W; Kähler C; Möller A; Möller U; Seewald HJ
    Z Geburtshilfe Neonatol; 2001; 205(5):189-94. PubMed ID: 11727665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.